Sandra Pinho

Title: Sandra Pinho: Innovator in Cancer Treatment

Introduction

Sandra Pinho is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of medical research, particularly in the development of innovative treatments for various diseases. With a total of 3 patents, her work focuses on targeting specific molecules to improve patient outcomes.

Latest Patents

Her latest patents include methods of treatment by targeting vascular cell adhesion molecule 1 (VCAM1) and macrophage erythroblast attacher (MAEA). These patents describe antibodies and antibody fragments that inhibit the activity of VCAM1 and/or MAEA. The formulations and kits comprising these antibodies are designed for use in treating cancers, sickle cell disease, and Polycythemia Vera. This groundbreaking work has the potential to transform therapeutic approaches in oncology and hematology.

Career Highlights

Sandra Pinho is affiliated with the Albert Einstein College of Medicine, where she conducts her research. Her innovative approaches and dedication to advancing medical science have positioned her as a key figure in her field.

Collaborations

Some of her notable coworkers include Paul S. Frenette and Qiaozhi Wei, who collaborate with her on various research projects. Their combined expertise enhances the impact of their work in the medical community.

Conclusion

Sandra Pinho's contributions to medical research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for new treatment options that can significantly improve patient care.